Literature DB >> 23956206

Designing cost-effective biopharmaceutical facilities using mixed-integer optimization.

Songsong Liu1, Ana S Simaria, Suzanne S Farid, Lazaros G Papageorgiou.   

Abstract

Chromatography operations are identified as critical steps in a monoclonal antibody (mAb) purification process and can represent a significant proportion of the purification material costs. This becomes even more critical with increasing product titers that result in higher mass loads onto chromatography columns, potentially causing capacity bottlenecks. In this work, a mixed-integer nonlinear programming (MINLP) model was created and applied to an industrially relevant case study to optimize the design of a facility by determining the most cost-effective chromatography equipment sizing strategies for the production of mAbs. Furthermore, the model was extended to evaluate the ability of a fixed facility to cope with higher product titers up to 15 g/L. Examination of the characteristics of the optimal chromatography sizing strategies across different titer values enabled the identification of the maximum titer that the facility could handle using a sequence of single column chromatography steps as well as multi-column steps. The critical titer levels for different ratios of upstream to dowstream trains where multiple parallel columns per step resulted in the removal of facility bottlenecks were identified. Different facility configurations in terms of number of upstream trains were considered and the trade-off between their cost and ability to handle higher titers was analyzed. The case study insights demonstrate that the proposed modeling approach, combining MINLP models with visualization tools, is a valuable decision-support tool for the design of cost-effective facility configurations and to aid facility fit decisions. 2013.
© 2013 American Institute of Chemical Engineers.

Keywords:  antibody titers; biopharmaceutical facility design; chromatography; mixed integer non-linear programming; monoclonal antibody purification

Mesh:

Substances:

Year:  2013        PMID: 23956206     DOI: 10.1002/btpr.1795

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  4 in total

1.  Economic Analysis of Batch and Continuous Biopharmaceutical Antibody Production: A Review.

Authors:  Ou Yang; Maen Qadan; Marianthi Ierapetritou
Journal:  J Pharm Innov       Date:  2019-01-25       Impact factor: 2.750

2.  Closed-loop optimization of chromatography column sizing strategies in biopharmaceutical manufacture.

Authors:  Richard Allmendinger; Ana S Simaria; Richard Turner; Suzanne S Farid
Journal:  J Chem Technol Biotechnol       Date:  2013-12-26       Impact factor: 3.174

3.  Optimization-based framework for resin selection strategies in biopharmaceutical purification process development.

Authors:  Songsong Liu; Spyridon Gerontas; David Gruber; Richard Turner; Nigel J Titchener-Hooker; Lazaros G Papageorgiou
Journal:  Biotechnol Prog       Date:  2017-05-18

4.  Economic evaluation of the primary recovery of tetracycline with traditional and novel aqueous two-phase systems.

Authors:  Mario A Torres-Acosta; Jorge F B Pereira; Mara G Freire; José M Aguilar-Yáñez; João A P Coutinho; Nigel J Titchener-Hooker; Marco Rito-Palomares
Journal:  Sep Purif Technol       Date:  2018-04-16       Impact factor: 7.312

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.